RECRUITING

Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery

Talk to us

Conditions

C.Surgical Procedure; Disruption of Wound, Suture

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Comparing the use of Stratafix Symmetric™ sutures to standard laparotomy closure sutures.

Official Title

A Randomized Controlled Trial Evaluating the Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery

Quick Facts

Study Start:2023-12-01
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06063577

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Participant is a male or female 18 years of age or older.
  2. 2. Participant is a current patient at West Michigan Cancer Center.
  3. 3. Participant is undergoing liver, pancreas or biliary or gastrointestinal surgery of a combination of the above, or other major oncological surgery.
  4. 4. Participant is willing and able to provide written informed consent before surgery.
  1. 1. Participant has hemodynamic instability at the conclusion of the surgery. (These subjects will be deemed disqualified).
  2. 2. Participant has history of previous VIH.
  3. 3. Participant has a mental condition rendering the subject incapable of understanding the nature, scope and consequences of the study.

Contacts and Locations

Study Contact

Wendi Mitchell
CONTACT
269-373-7443
research@wmcc.org

Principal Investigator

Gitonga Munene
PRINCIPAL_INVESTIGATOR
West Michigan Cancer Center

Study Locations (Sites)

West Michigan Cancer Center
Kalamazoo, Michigan, 49007
United States

Collaborators and Investigators

Sponsor: West Michigan Cancer Center

  • Gitonga Munene, PRINCIPAL_INVESTIGATOR, West Michigan Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-01
Study Completion Date2026-12

Study Record Updates

Study Start Date2023-12-01
Study Completion Date2026-12

Terms related to this study

Additional Relevant MeSH Terms

  • C.Surgical Procedure; Disruption of Wound, Suture